Jesus Hernandez
Gastroenterology · El Paso, TXNPI 1568462398
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $776 and has fallen 89.5% since, to $81 in 2021. That places this record below the midpoint for gastroenterology clinicians in TX, where the typical reported total is $3,104.
Across 105 payments — averaging $13.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$308
- AbbVie$298
- Pfizer$190
- Gilead$119
- Johnson & Johnson$84
- Intercept Pharmaceuticals, Inc.$77
- plus $390 from 11 others
What the payments were for
- Food & beverage$1,45199%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $308 |
| AbbVie | 18 | $298 |
| Pfizer | 22 | $190 |
| Gilead | 8 | $119 |
| Johnson & Johnson | 6 | $84 |
| Intercept Pharmaceuticals, Inc. | 5 | $77 |
| Shire North American Group Inc | 4 | $58 |
| Ironwood Pharmaceuticals, Inc | 3 | $57 |
| Merck | 3 | $52 |
| Redhill Biopharma Inc. | 2 | $40 |
| Daiichi Sankyo Inc. | 3 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Ambu Inc. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| UCB, Inc. | 1 | $16 |
How this compares
$1,467 in reported general payments places this provider in the 30th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in El Paso
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
- Parvez MantryDallas$958K
- Nadege GunnWaco$933K
- Brooks CashHouston$867K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.